| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 07/19/1984 | WO1984002721A1 Method for detecting, identifying, and quantitating organisms and viruses |
| 07/19/1984 | WO1984002653A1 Preparation having a high collagenolytic activity and pharmaceutical compositions containing it |
| 07/19/1984 | WO1984002651A1 Purification of antihemophilia factor viii by precipitation with zinc ions |
| 07/18/1984 | EP0113447A2 Process for the fractional separation of protein mixtures with membranes |
| 07/18/1984 | EP0113396A2 Liquid adherent disinfectant compositions for topical application and method of preparation |
| 07/18/1984 | EP0113394A1 Cyclopeptides for use in antibacterial therapy |
| 07/18/1984 | EP0113374A1 Polypeptide-toxin hybrid protein |
| 07/17/1984 | US4460765 Enzyme inhibitor produced by cultivation of streptomyces microorganisms |
| 07/17/1984 | US4460685 Method of enhancing the production of human γ Interferon |
| 07/17/1984 | US4460579 Thiazine and thiazepine containing compounds |
| 07/17/1984 | US4460576 Peptide and hormone agent containing the same as effective ingredient |
| 07/17/1984 | US4460574 Prophylaxis or treatment of interferon-sensitive diseases |
| 07/17/1984 | US4460561 Tumor localization and therapy with labeled antibodies specific to intracellular tumor-associated markers |
| 07/17/1984 | US4460559 Tumor localization and therapy with labeled antibodies specific to intracellular tumor-associated markers |
| 07/17/1984 | US4460502 Peptide, process for preparation thereof and use thereof |
| 07/17/1984 | CA1171008A1 Antibiotic a-4696 factors b.sub.1, b.sub.2, b.sub.3, c in1a xx, c.sub.3, and e in1 xx |
| 07/17/1984 | CA1171006A1 Hybrid cell line for producing monoclonal antibody to a human t cell antigen, antibody, and methods |
| 07/17/1984 | CA1170992A1 Oxygen carrier for blood substitute |
| 07/17/1984 | CA1170991A1 Products prepared from the serum thymic factor or its analogs and derivatives, a process for preparing these products, the use of these products as medicaments, tracers obtained from these products and the use of these tracers in detection processes |
| 07/17/1984 | CA1170990A1 Stabilized insulin preparations and method for their production |
| 07/11/1984 | EP0113319A2 Cell lines and their use for the production of proteins |
| 07/11/1984 | EP0113162A2 Anti-proliferative action of dsNRAs on tumor cells |
| 07/11/1984 | EP0113029A2 Dicyclic hexapeptides, processes for their preparation and pharmaceutical compositions containing them |
| 07/11/1984 | EP0112976A2 Novel DNA and R combinant plasmid containing the same |
| 07/11/1984 | EP0112940A1 Method of producing a tissue plasminogen activator and composition comprising same |
| 07/11/1984 | EP0040238B1 Plasminogen activators useful as therapeutic and diagnostic agents and their isolation |
| 07/10/1984 | US4459287 Immunopotentiator containing recin |
| 07/10/1984 | US4459225 Peptide amides and process for their manufacture |
| 07/10/1984 | US4458678 Method of promoting tissue generation at a wound |
| 07/10/1984 | CA1170618A1 Blood fractionation improvement |
| 07/10/1984 | CA1170599A1 N-acyl peptide compound, process for the preparation thereof and the pharmaceutical compositions |
| 07/10/1984 | CA1170598A1 Process for the preparation of cyclic peptide nuclei |
| 07/10/1984 | CA1170593A1 Hybrid cell line for producing monoclonal antibody to human cytotoxic and suppressor t cells, antibody, and methods |
| 07/10/1984 | CA1170592A1 Hybrid cell line for producing monoclonal antibody to human helper t cells, antibody, and methods |
| 07/05/1984 | WO1984002470A1 Medicinal preparation for the therapeutic treatment of peptic ulcer |
| 07/05/1984 | WO1984002467A1 Orally administered biologically active peptides and proteins |
| 07/04/1984 | EP0112809A1 Vasotocin derivatives |
| 07/04/1984 | EP0112656A2 Peptide compounds |
| 07/04/1984 | EP0112563A2 Solvent treatment of plasma protein products |
| 07/04/1984 | EP0112511A2 New compounds, pharmaceutical preparations containing same and process for their preparation |
| 07/04/1984 | EP0040641B1 Process for isolating and purifying a fraction capable of inhibiting mutagenicity of a mutagenic material from burdock juice |
| 07/04/1984 | EP0036415B1 Process for preparing a collagen product for medical and cosmetic use |
| 07/03/1984 | US4458078 Oxazole derivatives |
| 07/03/1984 | US4457917 Stimulation of cell growth |
| 07/03/1984 | US4457916 Method for stabilizing Tumor Necrosis Factor and a stable aqueous solution or powder containing the same |
| 07/03/1984 | US4457914 Fecundity of domestic livestock |
| 07/03/1984 | US4457913 Complete antigen drug and a process for producing it for nonspecific allergic disease therapy |
| 07/03/1984 | US4457867 Viricides, antitumor |
| 07/03/1984 | US4457865 Sialic acid specific slug lectin |
| 07/03/1984 | US4457864 Tridecapeptide hormone |
| 07/03/1984 | US4457863 Antitumor substance |
| 07/03/1984 | CA1170184A1 Psychotropic drugs |
| 07/03/1984 | CA1170183A1 Blood coagulation promoting product |
| 07/03/1984 | CA1170182A1 Blood-coagulation-promoting products and method of preparing them |
| 07/03/1984 | CA1170181A1 Process for the preparation of blood plasma fractions |
| 06/27/1984 | EP0112184A2 Antibiotic A51568 factors A and B |
| 06/27/1984 | EP0112149A2 Molecular cloning and characterization of a further gene sequence coding for human relaxin |
| 06/27/1984 | EP0112122A2 Plasminogen activator |
| 06/27/1984 | EP0112093A2 Novel monoclonal hybridoma and corresponding antibody |
| 06/27/1984 | EP0112036A1 Pharmacologically active peptides |
| 06/27/1984 | EP0111873A1 Derivatives of cis, endo-2-azabicyclo-(5.3.0)-decane-3-carboxylic acid, process for their preparation, compositions containing them and their use |
| 06/27/1984 | EP0111841A1 LHRH preparations for intranasal administration |
| 06/27/1984 | EP0111777A1 Plasma protein solution with a clotting activity, process for its preparation and its use in the treatment of disorders of the hemostatic system |
| 06/27/1984 | EP0009498B1 Effecting cellular uptake of molecules |
| 06/26/1984 | US4456748 Hybrid human leukocyte interferons |
| 06/26/1984 | US4456597 Interferon inducer, a process for producing the same and pharmaceutical composition containing the same |
| 06/26/1984 | US4456593 Antibiotic |
| 06/26/1984 | US4456592 Animal feeds |
| 06/26/1984 | US4456591 Separation from blood-coagulation factors ix and xii; antihemophilic agents |
| 06/26/1984 | US4456550 Vascular permeability factor |
| 06/26/1984 | CA1169854A1 Preparation process of novel hexapeptides |
| 06/26/1984 | CA1169774A1 Medication having penetration through cutaneous surfaces into articular and muscular areas |
| 06/21/1984 | WO1984002274A1 Activated, stabilized enzymes useful for wound healing |
| 06/20/1984 | EP0111389A2 Substantially pure porcine growth hormone, DNA sequences therefor, and expression vehicles and transfected microorganisms for the production of porcine growth hormone |
| 06/20/1984 | EP0111266A2 Substituted tetrapeptides |
| 06/19/1984 | US4455303 Renin inhibitors |
| 06/19/1984 | US4455302 Medical protein hydrolysate, process of making the same and processes of utilizing the protein hydrolysate to aid in healing traumatized areas |
| 06/19/1984 | US4455301 Antihemophilic factor concentrate |
| 06/19/1984 | US4455300 Fibronectin compositions |
| 06/19/1984 | US4455296 Hybrid cell lines producing monoclonal antibodies directed against Haemophilus influenzae |
| 06/19/1984 | US4455290 Anticoagulants |
| 06/19/1984 | US4455256 Solvent extraction, precipitation |
| 06/13/1984 | EP0110722A2 A heat-stable aqueous solution of human urine kallikrein |
| 06/13/1984 | EP0110716A2 Monoclonal antibodies against melanocytes and melanomas |
| 06/13/1984 | EP0110302A2 Method for producing monomeric interferons |
| 06/13/1984 | EP0110294A2 Agent for the treatment of osteoporose |
| 06/13/1984 | EP0110225A1 Bis-(benzoylthio)-carboxylic acids, their preparation and use in the production of active ingredients |
| 06/13/1984 | EP0110224A2 Benzoylthio compounds, their manufacture and use as medicines |
| 06/13/1984 | EP0110044A1 Human immune interferon protein and production thereof |
| 06/12/1984 | US4454117 Immunization against infection by Escherichia coli |
| 06/12/1984 | US4454116 Immunization of humans against enterotoxogenic infection by Escherichia coli |
| 06/12/1984 | US4454115 Fibroblast interferon |
| 06/12/1984 | US4454065 Oligopeptide prodrugs |
| 06/12/1984 | US4453939 Fibrinogen, factor xiii, thrombin, collagen carrier |
| 06/12/1984 | CA1169090A1 Continuous release pharmaceutical compositions |
| 06/12/1984 | CA1168985A1 L-arginine d,l-pyroglutamate as a pharmaceutical agent having an activity at the neuro-endocrinal level |
| 06/12/1984 | CA1168983A1 Method and system for the controlled release of biologically active substances to a body fluid |
| 06/12/1984 | CA1168982A1 Tissue adhesive |
| 06/12/1984 | CA1168981A1 Serum-derived "leukorecruitin" |
| 06/12/1984 | CA1168980A1 Wound healing compositions |